Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

513.88
Delayed Data
As of May 22
 -2.12 / -0.41%
Today’s Change
269.50
Today|||52-Week Range
519.46
+25.26%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Operating ActivitiesNet Income / Starting Line92.7M79.7M110.2M76.0M
 
 
 
 
 
Depreciation13.0M14.0M14.1M16.0M
 
 
 
 
 
Total Other Cash Flow89.1M84.9M123.7M113.1M
 
 
 
 
 
Funds From Operations170.8M160.7M231.9M194.2M
 
 
 
 
 
Funds From/For Other Operating Expenses-157.0M-2.9M33.6M281.7M
 
 
 
 
 
Net Cash Flow - Operating Activities327.8M163.6M198.3M-87.5M
 
 
 
 
 
 
InvestingIncrease In Investments-120.6M-103.9M-85.8M-95.8M
 
 
 
 
 
Decrease In Investments73.4M60.6M259.9M80.5M
 
 
 
 
 
Capital Expenditures-70.9M-79.8M-117.5M-114.2M
 
 
 
 
 
Net Cash Flow Investing-118.1M-123.1M56.6M-129.5M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-61.4M-276.0K-159.8M-9.9M
 
 
 
 
 
Net Proceeds Stock Sale8.0M17.7M45.2M76.3M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing126.9M99.3M105.0M155.6M
 
 
 
 
 
Other Uses - Financing144.9M110.9M243.2M145.7M
 
 
 
 
 
Net Cash Flow - Financing-71.4M5.9M-252.8M76.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.000.00----
 
Net Change In Cash138.3M46.4M2.2M-140.8M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account